Canagliflozin enhances senescent cell clearance, improving aging-related conditions

FHS
June 3, 2024
9:13 am

Whether sodium-glucose co-transporter 2 (SGLT2) inhibitors induce senolysis.

A conflict of interest behind the warning on Apellis’ eye drug? The optics are not good

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals

July 27, 2023

There’s a knowledge gap about miscarriages in the U.S., and researchers hope to close it

Megan Hanson was eight weeks pregnant in 2019 when she experienced a miscarriage — her sixth consecutive loss in as many years. It felt particularly

August 21, 2024

EMA’s CHMP recommends 10 new drugs as Pierre Fabre overactive bladder med wins approval

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.